Castellan Group increased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 114.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 32,482 shares of the company's stock after buying an additional 17,349 shares during the period. Procter & Gamble comprises 1.5% of Castellan Group's investment portfolio, making the stock its 24th largest holding. Castellan Group's holdings in Procter & Gamble were worth $5,536,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its holdings in Procter & Gamble by 20,758.5% during the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after acquiring an additional 7,913,335 shares in the last quarter. Capital Research Global Investors raised its holdings in shares of Procter & Gamble by 62.5% in the 4th quarter. Capital Research Global Investors now owns 7,398,120 shares of the company's stock valued at $1,240,294,000 after purchasing an additional 2,846,560 shares in the last quarter. Northern Trust Corp lifted its position in shares of Procter & Gamble by 10.1% during the 4th quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock worth $4,928,107,000 after purchasing an additional 2,703,757 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Procter & Gamble by 15.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after purchasing an additional 2,224,912 shares in the last quarter. Finally, APG Asset Management N.V. increased its holdings in Procter & Gamble by 1,709.5% in the fourth quarter. APG Asset Management N.V. now owns 2,006,298 shares of the company's stock valued at $324,825,000 after buying an additional 1,895,421 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have recently issued reports on the company. UBS Group set a $180.00 price objective on Procter & Gamble and gave the stock a "buy" rating in a research report on Wednesday. Redburn Partners set a $161.00 price target on Procter & Gamble in a report on Thursday, May 1st. Erste Group Bank lowered shares of Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Morgan Stanley set a $180.00 price objective on shares of Procter & Gamble and gave the stock an "overweight" rating in a research report on Friday, April 25th. Finally, JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Nine analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $175.88.
View Our Latest Stock Analysis on PG
Procter & Gamble Price Performance
Shares of NYSE PG opened at $150.30 on Friday. The stock has a fifty day moving average price of $160.13 and a 200 day moving average price of $164.05. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.70 and a quick ratio of 0.50. The company has a market cap of $352.38 billion, a PE ratio of 23.09, a P/E/G ratio of 4.27 and a beta of 0.40.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.56%. The business's revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the business earned $1.40 EPS. Sell-side analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be given a dividend of $1.0568 per share. The ex-dividend date is Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.8%. Procter & Gamble's payout ratio is presently 67.14%.
Insider Transactions at Procter & Gamble
In other news, insider Moses Victor Javier Aguilar sold 10,520 shares of the firm's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $158.67, for a total value of $1,669,208.40. Following the completion of the sale, the insider directly owned 25,182 shares of the company's stock, valued at $3,995,627.94. This trade represents a 29.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.18% of the company's stock.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
